Healthcare provider profile · identity verified

Andrew Last, MD

Family Practice · TOMAH, WI · NPI 1225353576

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	565	141
Lisinopril	Lisinopril	258	68
Levothyroxine Sodium	Levothyroxine Sodium	202	53
Metoprolol Succinate	Metoprolol Succinate	198	56
Gabapentin	Gabapentin	186	52
Hydrochlorothiazide	Hydrochlorothiazide	173	46
Famotidine	Famotidine	159	38
Amlodipine Besylate	Amlodipine Besylate	155	39
Simvastatin	Simvastatin	152	40
Losartan Potassium	Losartan Potassium	144	40
Albuterol Sulfate Hfa	Albuterol Sulfate	124	44
Metoprolol Tartrate	Metoprolol Tartrate	123	27
Metformin Hcl Er	Metformin Hcl	122	34
Eliquis	Apixaban	120	24
Furosemide	Furosemide	116	31
Tamsulosin Hcl	Tamsulosin Hcl	112	28
Fluticasone Propionate	Fluticasone Propionate	110	32
Omeprazole	Omeprazole	107	35
Pantoprazole Sodium	Pantoprazole Sodium	104	22
Jardiance	Empagliflozin	94	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	15
Sertraline Hcl	Sertraline Hcl	83	22
Warfarin Sodium	Warfarin Sodium	74	17
Ezetimibe	Ezetimibe	72	16
Allopurinol	Allopurinol	71	17
Potassium Chloride	Potassium Chloride	69	18
Duloxetine Hcl	Duloxetine Hcl	64	15
Clopidogrel	Clopidogrel Bisulfate	61	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	60	11
Metformin Hcl	Metformin Hcl	60	19
Ozempic	Semaglutide	57	suppressed
Trazodone Hcl	Trazodone Hcl	53	17
Rosuvastatin Calcium	Rosuvastatin Calcium	50	16
Alendronate Sodium	Alendronate Sodium	49	13
Carvedilol	Carvedilol	49	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	11
Morphine Sulfate Er	Morphine Sulfate	46	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	46	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	12
Oxycodone Hcl	Oxycodone Hcl	45	13
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Spironolactone	Spironolactone	41	12
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Alprazolam	Alprazolam	35	suppressed
Methenamine Hippurate	Methenamine Hippurate	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	17
Montelukast Sodium	Montelukast Sodium	33	suppressed
Glipizide Er	Glipizide	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	11
Atenolol	Atenolol	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	13
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Potassium Citrate Er	Potassium Citrate	29	suppressed
Sucralfate	Sucralfate	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Estradiol	Estradiol	28	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Finasteride	Finasteride	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Tresiba Flextouch U-100	Insulin Degludec	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Lovastatin	Lovastatin	20	suppressed
Lyumjev Kwikpen U-100	Insulin Lispro-Aabc	20	suppressed
Prednisone	Prednisone	20	16
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Nystatin	Nystatin	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Lorazepam	Lorazepam	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Torsemide	Torsemide	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fycompa	Perampanel	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Progesterone	Progesterone, Micronized	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error